Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (277)	2/11/2003 11:12:54 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

GILD Traded as high as 35 at 9.42AM but its chart still will not look good until it can close at 40 (above its Nov.-Dec. Hs) It announced today that its emtricitabine has helped suppress the AIDS virus. (GILD acquired the drug after it bought VIRS, the merger was completed on Jan.23) siliconinvestor.com The stock still has to close above its Jan.30 H of 37.35 and its Jan.16 H of 38.38 before it can test its Nov.-Dec. Hs. siliconinvestor.com Bernard

To: Jibacoa who wrote (277)	2/12/2003 9:45:04 PM
From: Jibacoa	Respond to of 3722

AVN Was down 17.79% today on volume of 2.48M (about 12x its daily average) after it reported financial results for the 1stQ and the fiscal year ended December 31. biz.yahoo.com The revenues suffered when compared to the 1st Q the previous year, since it didn't have the $5M payment it received from GSK and earning suffered due to increased R&D expenses related to having several products in clinical trials.<g> The stock didn't completely retrace yesterday's gain and although it tested its October 28 H of 1.29 it was able to close above it. The net loss per share for the 1stQ was $0.07 compared with an income of $0.04 the previous year. And AVN reportedly had $27M in cash on Dec.31 and a working capital of $20M on December 31, compared to $13.2M in cash and a working capital of $5.9M on Sep.30 siliconinvestor.com Bernard